CIK 0001585608
- Non-accelerated filer
- Smaller reporting company
Jaguar Health, Inc.
Sign in to watch- Ticker
- JAGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 415-371-8300
- Business address
- 200 PINE STREET SUITE 400, SAN FRANCISCO, CA, 94104
- Former names
- Jaguar Animal Health, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 83 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-28 | Siegel Jonathan B. Director | Grant or award · Restricted stock units | +85,900 | 85,900 | ||
| 2022-03-28 | MICEK JOHN Director | Grant or award · Restricted stock units | +85,900 | 85,900 | ||
| 2022-03-28 | BOCHNOWSKI JAMES J Director | Grant or award · Restricted stock units | +96,015 | 96,015 | ||
| 2022-03-28 | Chaturvedi Pravin R Chief Scientific Officer | Grant or award · Restricted stock units | +195,934 | 195,934 | ||
| 2022-03-28 | Lizak Carol R. Chief Financial Officer | Grant or award · Restricted stock units | +97,025 | 97,025 | ||
| 2022-03-28 | Wolin Jonathan S. Chief of Staff, CCO & GC | Grant or award · Restricted stock units | +196,018 | 196,018 | ||
| 2022-03-28 | King Steven R. Chief of Sustainable Supply | Grant or award · Restricted stock units | +137,685 | 137,685 | ||
| 2022-03-28 | CONTE LISA A CEO and President | Grant or award · Restricted stock units | +606,280 | 606,280 | ||
| 2022-03-28 | CONTE LISA A CEO and President | Grant or award · Restricted stock units | +25,000 | 25,000 | ||
| 2021-09-13 | Lizak Carol R. Chief Financial Officer | Purchase | +7,968 | $2.51 | $20K | 7,968 |
| 2021-09-13 | CONTE LISA A CEO and President | Purchase | +7,968 | $2.51 | $20K | 8,003 |
| 2021-06-04 | BOCHNOWSKI JAMES J Director | Sale | −152 | $1.74 | $264 | 954,390 |
| 2021-06-03 | BOCHNOWSKI JAMES J Director | Sale | −292 | $1.75 | $511 | 954,542 |
| 2021-05-18 | Siegel Jonathan B. Director | Grant or award · Stock option (right to buy) | +72,750 | 72,750 | ||
| 2021-05-18 | Siegel Jonathan B. Director | Grant or award · Restricted stock units | +36,400 | 36,400 | ||
| 2021-05-18 | MICEK JOHN Director | Grant or award · Stock option (right to buy) | +72,750 | 72,750 | ||
| 2021-05-18 | MICEK JOHN Director | Grant or award · Restricted stock units | +36,400 | 36,400 | ||
| 2021-05-18 | Divis Gregory J Director | Grant or award · Stock option (right to buy) | +72,750 | 72,750 | ||
| 2021-05-18 | Divis Gregory J Director | Grant or award · Restricted stock units | +36,400 | 36,400 | ||
| 2021-05-18 | BOCHNOWSKI JAMES J Director | Grant or award · Stock option (right to buy) | +78,750 | 78,750 |
Page 9 of 10 · 185 trades